FTI-2148

Modify Date: 2024-01-16 16:19:31

FTI-2148 Structure
FTI-2148 structure
Common Name FTI-2148
CAS Number 251577-09-0 Molecular Weight 452.569
Density 1.3±0.1 g/cm3 Boiling Point 730.1±60.0 °C at 760 mmHg
Molecular Formula C24H28N4O3S Melting Point N/A
MSDS N/A Flash Point 395.4±32.9 °C

 Use of FTI-2148


FTI-2148 is a RAS C-terminal mimetic dual farnesyl transferase (FT-1) and geranylgeranyl transferase-1 (GGT-1) inhibitor with IC50s of 1.4 nM and 1.7 μM for FT-1 and GGT-1, respectively[1].

 Names

Name N-[(5-{[(1H-Imidazol-4-ylmethyl)amino]methyl}-2'-methyl-2-biphenylyl)carbonyl]-L-methionine
Synonym More Synonyms

 FTI-2148 Biological Activity

Description FTI-2148 is a RAS C-terminal mimetic dual farnesyl transferase (FT-1) and geranylgeranyl transferase-1 (GGT-1) inhibitor with IC50s of 1.4 nM and 1.7 μM for FT-1 and GGT-1, respectively[1].
Related Catalog
Target

IC50: 1.4 nM (FT-1); 1.7 μM (GGT-1)[1]

In Vitro FTI-2148 (30 μM) inhibits the farnesylation of the exclusively farnesylated protein HDJ2 in all 3 RAS-transformed NIH3T3 cells. Western Blot Analysis[2] Cell Line: KRAS HRAS, and NRAS-transformed NIH3T3 cells  Concentration: 30 μM Incubation Time: Result: Inhibited the prenylation of KRAS and NRAS.
In Vivo FTI-2148 (subcutaneous injection; 100 mg/kg/day; 14 days) results in breast tumor regression in a ras transgenic mouse model[1]. FTI-2148 (subcutaneous injection; 100 mg/kg/day; 4 days) results in 85–88% inhibition of FTase with no inhibition of GGTase I enzymatic activity in breast tumors from mice in vivo settings[1]. Animal Model: Ras transgenic mouse model[1] Dosage: 100 mg/kg/day Administration: Subcutaneous injection; 100 mg/kg/day; 14 days Result: Induced regression by 87 ± 3% of mammary carcinomas in mice.
References

[1]. Sun J, et al. Geranylgeranyltransferase I inhibitor GGTI-2154 induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice.Cancer Res. 2003 Dec 15;63(24):8922-9.

[2]. Sun J, et al. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine. Cancer Res. 1999 Oct 1;59(19):4919-26.

[3]. Kazi A, et al. Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors.Clin Cancer Res. 2019 Oct 1;25(19):5984-5996.

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Boiling Point 730.1±60.0 °C at 760 mmHg
Molecular Formula C24H28N4O3S
Molecular Weight 452.569
Flash Point 395.4±32.9 °C
Exact Mass 452.188202
LogP 2.45
Vapour Pressure 0.0±2.5 mmHg at 25°C
Index of Refraction 1.626

 Safety Information

Hazard Codes Xi

 Synonyms

L-Methionine, N-[[5-[[(1H-imidazol-4-ylmethyl)amino]methyl]-2'-methyl[1,1'-biphenyl]-2-yl]carbonyl]-
N-[(5-{[(1H-Imidazol-4-ylmethyl)amino]methyl}-2'-methyl-2-biphenylyl)carbonyl]-L-methionine
N-[(5-{[(1H-imidazol-4-ylmethyl)amino]methyl}-2'-methylbiphenyl-2-yl)carbonyl]-L-methionine
Top Suppliers:I want be here


Get all suppliers and price by the below link:

FTI-2148 suppliers

FTI-2148 price